Current Issue

Application of Quality Risk Management to Process Validation

Robert Dream, Managing Director, HDR Company LLC

A Holistic Phase Appropriate Strategy for HCP-Limits and HCP Characterization

Dr. Markus Haindl, Global Head Gene Therapy Technical Research & Development, Roche Di...

Strategies for Extractable and Leachable Risk Assessment of Polymeric Single Use Systems U...

Ping Wang, Director, Johnson & Johnson

Use of Non-Contact Raman Spectroscopy to Derive Reaction Kinetics

Richard Hart, Senior Director – Head of Automation and Data Science (Previously Asso...

Amsphere A3

JSR Life Sciences



Headline News

RYBREVANT FASPRO combination shows 77% response rate in first-line advanced head and neck cancer


Ris-Rez cuts progression risk by 67% in Phase III relapsed osteosarcoma trial


Jemperli achieves 76% complete response rate in Phase II rectal cancer trial


Read All Headlines

Upcoming Webinars

View All Upcoming Webinars

Past Webinars

A Data Driven Biopharmaceutical Manufacturing Facility-Plug and Produce – Shaping the Future Together

Presented by Josef Trapl Global Manufacturing & Supply, Head of MSci Innovation at Takeda and Petter Moree, Global Industry Principal at OSIsoft
04th March 2021


PDA Technical Report on Low Endotoxin Recovery: Implications to the Industry

Presented by Dr Friedrich von Wintzingerode, Senior Manager, Global Analytical Science & Technology (gASAT) Microbiology, Global QC bei Roche
03rd May 2019


Overcoming Antibody-Drug Conjugate (ADC) Process Development & Manufacturing Challenges

Presented by Dr. Jimmy Li, CEO of WuXi XDC (a WuXi Biologics subsidiary)
23rd February 2022


View All Past Webinars

Featured Companies

 

View All Companies

© 2026 biopharma-asia.com. All rights reserved. Privacy Policy

Biopharma Asia